For instance, Gautheron et al. found that the liver of NASH patients expressed high levels of RIP3 [14], and showed that RIP3-dependent necroptosis controlled liver fibrosis in a mouse model of methionine and choline-deficient diet-induced steatohepatitis [14]. Here, RIPK3 is linked to metabolic dysfunction-associated steatohepatitis.